1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
About this market
The technological advances in drug delivery to push growth in the market. The increasing need for novel drug delivery systems has led to the advent of intravitreal implants, which are small hair-stranded sized devices that are implanted into the middle layer of the eye. The analysts have predicted that the ocular inflammation treatment market will register a CAGR of more than 6% by 2023.
Market Overview
Growing awareness of eye care
Several organizations are conducting awareness campaigns on various eye-related diseases. Thus, the rising awareness about eye related diseases, including ocular inflammation is expected to contribute to the market growth during the forecast period.
Growing preference for surgeries
The global ocular inflammation market poses high threat from alternative treatment options such as non-invasive surgeries such as LASER treatments and invasive surgeries such as vitrectomy.
For the detailed list of factors that will drive and challenge the growth of the ocular inflammation treatment market during the 2019-2023, view the full report.
Competitive Landscape
The market appears to be concentrated and with the presence of several companies including AbbVie and Bausch Health, the competitive environment is quite intense. Factors such as the growing awareness of eye care and the technological advances in drug delivery, will provide considerable growth opportunities to ocular inflammation treatment manufactures. AbbVie, Bausch Health, Novartis, and Pfizer are some of the major companies covered in this report.
The technological advances in drug delivery to push growth in the market. The increasing need for novel drug delivery systems has led to the advent of intravitreal implants, which are small hair-stranded sized devices that are implanted into the middle layer of the eye. The analysts have predicted that the ocular inflammation treatment market will register a CAGR of more than 6% by 2023.
Market Overview
Growing awareness of eye care
Several organizations are conducting awareness campaigns on various eye-related diseases. Thus, the rising awareness about eye related diseases, including ocular inflammation is expected to contribute to the market growth during the forecast period.
Growing preference for surgeries
The global ocular inflammation market poses high threat from alternative treatment options such as non-invasive surgeries such as LASER treatments and invasive surgeries such as vitrectomy.
For the detailed list of factors that will drive and challenge the growth of the ocular inflammation treatment market during the 2019-2023, view the full report.
Competitive Landscape
The market appears to be concentrated and with the presence of several companies including AbbVie and Bausch Health, the competitive environment is quite intense. Factors such as the growing awareness of eye care and the technological advances in drug delivery, will provide considerable growth opportunities to ocular inflammation treatment manufactures. AbbVie, Bausch Health, Novartis, and Pfizer are some of the major companies covered in this report.
Note: Product cover images may vary from those shown
PART 01: EXECUTIVE SUMMARYPART 08: CUSTOMER LANDSCAPEPART 10: DECISION FRAMEWORKPART 12: MARKET TRENDS
PART 02: SCOPE OF THE REPORT
PART 03: MARKET LANDSCAPE
PART 05: FIVE FORCES ANALYSIS
PART 06: MARKET SEGMENTATION BY PRODUCT
PART 07: MARKET SEGMENTATION BY ROA
PART 09: GEOGRAPHIC LANDSCAPE
PART 11: DRIVERS AND CHALLENGES
PART 13: VENDOR LANDSCAPE
PART 14: VENDOR ANALYSIS
PART 15: APPENDIX
List of Exhibits
Note: Product cover images may vary from those shown
Global Ocular Inflammation Treatment Market 2019-2023
The author of the report recognizes the following companies as the key players in the global ocular inflammation treatment market: AbbVie, Bausch Health, Novartis, and Pfizer.
Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the technological advances in drug delivery.”
According to the report, one of the major drivers for this market is the growing awareness of eye care.
Further, the report states that one of the major factors hindering the growth of this market is the growing preference for surgeries.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
The author of the report recognizes the following companies as the key players in the global ocular inflammation treatment market: AbbVie, Bausch Health, Novartis, and Pfizer.
Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the technological advances in drug delivery.”
According to the report, one of the major drivers for this market is the growing awareness of eye care.
Further, the report states that one of the major factors hindering the growth of this market is the growing preference for surgeries.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
A selection of companies mentioned in this report includes:
- AbbVie
- Bausch Health
- Novartis
- Pfizer
Note: Product cover images may vary from those shown
